MRNA - Hot Stocks: COVID vaccine stocks fall; SLQT cut in half; MRTX sets low; AA hits high; TDC rallies on earnings

The major U.S. equity averages managed to build strength throughout the session on Tuesday, leading to larger-than-1% advances in the Dow and Nasdaq. The S&P 500 trailed a bit but still posted a notable climb. However, even with the gains, stocks remained in a general holding pattern after bouncing back from January's massive losses. While stocks generally posted gains, shares of COVID vaccine makers were left out of the upswing. Signs that the market may have peaked weighed on shares of Novavax (NASDAQ:NVAX), Moderna (NASDAQ:MRNA) and BioNTech (NASDAQ:BNTX). SelectQuote (NYSE:SLQT) was also left out of the broader advance. Shares lost nearly half their value on weak earnings and guidance. Mirati Therapeutics (NASDAQ:MRTX) also posted a notable decline on the session, amid worries about the prospects for its developmental lung cancer drug. Looking at some of the day's standout gainers, Teradata (NYSE:TDC) expanded its value by more than a quarter on

For further details see:

Hot Stocks: COVID vaccine stocks fall; SLQT cut in half; MRTX sets low; AA hits high; TDC rallies on earnings